ClinicalTrials.gg
Active, not recruitingNCT07733284SWEAT-TBIUpdated Oct 13, 2026

Home-Based Walking for Thinking Skills in Persons With TBI

An Early Phase 1 interventional study of Walking in Traumatic Brain Injury (TBI) Patients, sponsored by Kessler Foundation. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Kessler Foundation · Early Phase 1, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Apr 2026, registered Jul 2026).
Updated Oct 13, 2026Now Active, not recruitingGo to Updates ↓
Phase
Early Phase 1
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 44 studies in Brain Injuries, Traumatic by Kessler Foundation — 14 open to participants now, 16 under way, none of them phase 3. Brain Injuries, Traumatic · Kessler Foundation.

Planned enrollment
19th of 42
40 · median 36
Started
2026
the only one that year
Phase 1
2 of 44
1 open now
Primary completion
2026-12
later than 10 of 15 live
Registered
44th of 44
by date

Among the 44 studies in Brain Injuries, Traumatic by Kessler Foundation, this one is the 19th largest by planned enrollment of the 42 interventional ones that give a count, is the only one that started in 2026, is one of 2 in phase 1, reaches primary completion later than 10 of the 15 other live ones, and was the 44th registered.

Brain Injuries, Traumatic

1,721 studies on the registry are indexed under Brain Injuries, Traumatic; 447 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

14 of the 44 studies in Brain Injuries, Traumatic by Kessler Foundation are open now, in 1 country. Recruiting first, the newest first:

9 more — sign in →

By country, each count listing its studies:

All 14 open studies →

Where they have run

Who these studies take

Of the 281 Brain Injuries, Traumatic studies recruiting now, 120 (43%) set no upper age limit and 119 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Brain Injuries, Traumatic by Kessler Foundation, or all of them as a file.
02

Study summary

The purpose of this research study is to investigate the effects of a home-based 3-month long walking exercise program on cognitive (thinking) performance in persons with TBI. As a participant, you will complete this 3-month exercise program now or after a 3-month wait period.

Read the detailed description

This study involves no in-person visits to Kessler Foundation and takes place at home.

The first study activity will last about 1 hour in total and will involve using videoconferencing software (Zoom) to take tests of thinking (e.g., matching shapes and number, learning a list of words). You will then complete several brief questionnaires about everyday activities and TBI symptoms over the computer.

You will then be randomly picked (like the flip of a coin) by a computer to participate in one of two groups. You will have a 50/50 chance of being placed in either group.

One group will complete 3-months of walking exercise at home. The exercise program is based on activity guidelines for people with TBI and will be monitored by a trained exercise leader. You will be asked to walk 3 times per week. The first two weeks will require you to walk for 10 minutes at a time, and that duration will increase throughout the 3-months. You will have a dedicated trainer to help get started, answer questions, and support you throughout the programs. You will have regular meetings with this trainer by video conference (Zoom). You will be sent a FitBit to wear on your wrist while exercising to track your steps, and that you will be allowed to keep when the study ends.

The other group will stick to a regular routine during this 3-month period (i.e., wait-list group).

At the end of the 3-month exercise program, you will repeat the thinking tests and questionnaires. The wait-list group will be given the exercise prescription after this last Zoom session.

03

Conditions studied

  • Traumatic Brain Injury (TBI) Patients

Keywords

  • walking
  • thinking
  • fitbit
  • exercise
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Definitive TBI diagnosis at least 1 year prior, verified by medical records
  • Self-report problems with thinking skills since the TBI diagnosis (e.g., processing information, learning or remembering, organizing, multitasking)
  • Between the ages of 18 and 65
  • Access to internet and email
  • Fluent in English
  • Can walk at a brisk pace without using an assistive device
  • Not fallen due to mobility issues from their TBI in the past 6 months
  • Do not currently meet public health guidelines for physical activity
  • Have problems with thinking performance

Exclusion criteria

Exclusion Criteria:

  • I currently have uncontrolled major depression
  • I have a history of schizophrenia, bipolar disorder I or II, or substance-abuse disorders
  • I am regularly taking medications that can affect my thinking, such as antipsychotics or benzodiazepines. Study staff will review my medications to determine if I am taking any that would make me ineligible for this study
  • I have known/diagnosed cardiovascular disease including uncontrolled hypertension, diabetes, or kidney disease
  • I am unable to make everyday decisions on my own
05

Study design

Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Behavioral: Exercise

    One group will complete 3-months of walking exercise at home. The exercise program is based on activity guidelines for people with TBI and will be monitored by a trained exercise leader. You will be asked to walk 3 times per week. The first two weeks will require you to walk for 10 minutes at a time, and that duration will increase throughout the 3-months. You will have a dedicated trainer to help get started, answer questions, and support you throughout the programs. You will have regular meetings with this trainer by video conference (Zoom). You will be sent a FitBit to wear on your wrist while exercising to track your steps, and that you will be allowed to keep when the study ends.

    Behavioral: Walking

  • No intervention
    Wait List

    The other group will stick to a regular routine during this 3-month period (i.e., wait-list group).

Interventions

  • BehavioralWalking

    One group will complete 3-months of walking exercise at home. The exercise program is based on activity guidelines for people with TBI and will be monitored by a trained exercise leader. You will be asked to walk 3 times per week. The first two weeks will require you to walk for 10 minutes at a time, and that duration will increase throughout the 3-months. You will have a dedicated trainer to help get started, answer questions, and support you throughout the programs. You will have regular meetings with this trainer by video conference (Zoom). You will be sent a FitBit to wear on your wrist while exercising to track your steps, and that you will be allowed to keep when the study ends.

06

What researchers measure

Primary outcomes

  1. Adverse Events

    Safety will be primarily measured as adverse events, specifically during the remote walking intervention.

    Time frame: Through study completion, which is 3 months for intervention and 6 months for wait list.

  2. Adherence

    Adherence is measured as the number of exercise sessions attended compared to the number of total sessions prescribed.

    Time frame: Through study completion, which is 3 months for intervention and 6 months for wait list.

  3. Compliance

    Compliance will be measured as the number of exercise sessions completed as prescribed (i.e., intensity and duration).

    Time frame: Through study completion, which is 3 months for intervention and 6 months for wait list.

Secondary outcomes

  1. Processing Speed

    Neuropsychological assessments will be administered to measure processing speed using the symbol digit modalities test (SDMT).

    Time frame: Baseline and follow-up (12-weeks post-baseline)

  2. Learning/Memory

    Neuropsychological assessments will be administered to measure processing learning and memory using the California Verbal Learning Test (CVLT).

    Time frame: Baseline and follow-up (12-weeks post-baseline)

  3. Executive function

    Neuropsychological assessments will be administered to measure executive function using the Delis-Kaplan Executive Function System (DKEFS).

    Time frame: Baseline and follow-up (12-weeks post-baseline)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — We plan to share sample data on safety measures, adherence, and compliance.

Supporting information: Study protocol, Statistical analysis plan

Time frame: These data will be shared upon completion of data collection (estimated 12/2026) and will be available for three years.

Access criteria: Interested parties can request data be shared directly form the PI.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.

Of 27 phase 1 interventional studies under Brain Injuries, Traumatic, half reached primary completion within 52 months of starting (the median), counting those still running; a quarter within 34 and three quarters within 66. This study's planned 8 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2026
First posted
Jul 29, 2026
StartActual
Apr 15, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Recruiting→Active, not recruiting
    + 2 other changes: contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07733284
Lead sponsor
Kessler Foundation
Responsible party
Carly Wender (Principal Investigator, Kessler Foundation) — Principal investigator
First posted
Jul 29, 2026
Start date
Apr 15, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Oct 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion